
Argent Biopharma and Auscann have joined forces in a deal designed to “accelerate cannabinoid-based pharmaceutical development”. […]
The post Argent Biopharma and Auscann sign deal to ‘enhance drug development’ appeared first on Cannabiz.
Continue reading...